Company Filing History:
Years Active: 2010-2011
Title: Sunil Jadhav: Innovator in Medicinal Chemistry
Introduction
Sunil Jadhav is a prominent inventor based in Mumbai, India. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target tumor necrosis factor-alpha (TNF-α). His work is crucial in addressing various inflammatory disorders.
Latest Patents
Sunil Jadhav holds two patents related to fused tricyclic compounds that act as inhibitors of TNF-α. These compounds are designed to be effective medicaments for the treatment and prevention of disorders caused by increased TNF-α activity, especially inflammations. The detailed chemical formulations of these compounds include specific structural components that enhance their efficacy.
Career Highlights
Sunil Jadhav is currently associated with Piramal Life Sciences Limited, where he continues to innovate in the field of pharmaceuticals. His research focuses on developing new therapeutic agents that can significantly improve patient outcomes in inflammatory diseases.
Collaborations
He collaborates with notable colleagues such as Bansi Lal and Usha Ghosh, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Sunil Jadhav's work exemplifies the impact of innovative research in medicinal chemistry. His patents and ongoing contributions are vital in the fight against inflammatory disorders, showcasing the importance of scientific advancement in healthcare.